Insider Buying Propped Summers Value Partners’ Massive Gains in Bioanalytical Systems (BASI) Summers Value Partners, an investment management firm, published its ‘Summers Value Fund LP’ fourth-quarter 2020 Investor Letter – a copy of which can be downloaded here. A net return of 14.7% was recorded by the fund for the Q4 of 2020, below its Russell 2000 benchmark that returned 18.40%. You can view the fund’s top 10 holdings to have a peek at their top bets for 2021. Summers Value Partners, in their Q4 2020 Investor Letter said that they acquired a new position in Bioanalytical Systems, Inc. (NASDAQ: BASI) after series of insider stock purchases attempts. Bioanalytical Systems, Inc. is a company that provides research and development resources and then sells the information to biotechnology, pharmaceutical and medical related companies. Bioanalytical Systems, Inc. currently has a $136 million market cap. For the past 3 months, BASI delivered a massive 145.02% return and settled at $12.30 per share at the closing of January 27th.